154 related articles for article (PubMed ID: 3781947)
1. VIP and PHM and their role in nonadrenergic inhibitory responses in isolated human airways.
Palmer JB; Cuss FM; Barnes PJ
J Appl Physiol (1985); 1986 Oct; 61(4):1322-8. PubMed ID: 3781947
[TBL] [Abstract][Full Text] [Related]
2. Comparison of vasoactive intestinal peptide and isoproterenol relaxant effects in isolated cat airways.
Altiere RJ; Diamond L
J Appl Physiol Respir Environ Exerc Physiol; 1984 Apr; 56(4):986-92. PubMed ID: 6725078
[TBL] [Abstract][Full Text] [Related]
3. Is peptide histidine isoleucine an inhibitory nonadrenergic noncholinergic neurotransmitter in the rat gastric fundus?
D'Amato M; Currò D; Ciabattoni G; Lefebvre RA
Arch Int Pharmacodyn Ther; 1990; 303():216-31. PubMed ID: 1973609
[TBL] [Abstract][Full Text] [Related]
4. The effects of vasoactive intestinal peptide (VIP) antagonists, and VIP and peptide histidine isoleucine antisera on non-adrenergic, non-cholinergic relaxations of tracheal smooth muscle.
Ellis JL; Farmer SG
Br J Pharmacol; 1989 Mar; 96(3):513-20. PubMed ID: 2720290
[TBL] [Abstract][Full Text] [Related]
5. Peptide histidine methionine and vasoactive intestinal peptide: occurrence and relaxant effect in the human female reproductive tract.
Palle C; Ottesen B; Jørgensen J; Fahrenkrug J
Biol Reprod; 1989 Dec; 41(6):1103-11. PubMed ID: 2624870
[TBL] [Abstract][Full Text] [Related]
6. Effects of peptidases on non-adrenergic, non-cholinergic inhibitory responses of tracheal smooth muscle: a comparison with effects on VIP- and PHI-induced relaxation.
Ellis JL; Farmer SG
Br J Pharmacol; 1989 Mar; 96(3):521-6. PubMed ID: 2655804
[TBL] [Abstract][Full Text] [Related]
7. Relaxant effects of vasoactive intestinal peptide and peptide histidine isoleucine in human and bovine pulmonary arteries.
Greenberg B; Rhoden K; Barnes PJ
Blood Vessels; 1987; 24(1-2):45-50. PubMed ID: 3567364
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cholinergic neurotransmission by vasoactive intestinal peptide and peptide histidine isoleucine in guinea-pig tracheal smooth muscle.
Ellis JL; Farmer SG
Pulm Pharmacol; 1989; 2(2):107-12. PubMed ID: 2562470
[TBL] [Abstract][Full Text] [Related]
9. Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropin-releasing hormone with PHM or VIP.
Watanobe H; Tamura T
J Clin Endocrinol Metab; 1994 Jun; 78(6):1372-7. PubMed ID: 8200939
[TBL] [Abstract][Full Text] [Related]
10. Effects of VIP and PHM in human intracervical arteries.
Hansen V; Ottesen B; Allen J; Maigaard S; Forman A
Acta Obstet Gynecol Scand; 1988; 67(8):699-701. PubMed ID: 3250182
[TBL] [Abstract][Full Text] [Related]
11. Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro.
Ward JK; Belvisi MG; Fox AJ; Miura M; Tadjkarimi S; Yacoub MH; Barnes PJ
J Clin Invest; 1993 Aug; 92(2):736-42. PubMed ID: 8349813
[TBL] [Abstract][Full Text] [Related]
12. Effect of the neuropeptides vasoactive intestinal peptide, peptide histidine methionine and substance P on human major salivary gland secretion.
Del Fiacco M; Quartu M; Ekström J; Melis T; Boi M; Isola M; Loy F; Serra MP
Oral Dis; 2015 Mar; 21(2):216-23. PubMed ID: 24725136
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal polypeptide (VIP) and peptide histidine methionine (PHM) in human penile corpus cavernosum tissue and circumflex veins: localization and in vitro effects.
Kirkeby HJ; Fahrenkrug J; Holmquist F; Ottesen B
Eur J Clin Invest; 1992 Jan; 22(1):24-30. PubMed ID: 1348474
[TBL] [Abstract][Full Text] [Related]
14. Anomalous growth hormone response to vasoactive intestinal peptide and peptide histidine methionine in patients with prolactinoma or hypothalamic hyperprolactinemia.
Watanobe H; Tamura T; Takahashi K
Neuropeptides; 1994 Aug; 27(2):137-42. PubMed ID: 7991068
[TBL] [Abstract][Full Text] [Related]
15. Relaxation of isolated guinea pig trachea, bronchi and pulmonary arteries produced by vasoactive intestinal peptide (VIP).
Hand JM; Laravuso RB; Will JA
Eur J Pharmacol; 1984 Feb; 98(2):279-84. PubMed ID: 6714311
[TBL] [Abstract][Full Text] [Related]
16. Relaxant effect of rat PHI, PHI-Gly and PHV(1-42) in the rat gastric fundus.
Lefebvre RA; Sas S; Cauvin A
Peptides; 1991; 12(2):271-4. PubMed ID: 1648712
[TBL] [Abstract][Full Text] [Related]
17. A further study on the stimulatory effect of peptide histidine methionine on growth hormone secretion in acromegaly: a dose-related study and a comparison with vasoactive intestinal peptide.
Watanobe H; Takebe K
Neuropeptides; 1992 Oct; 23(2):115-9. PubMed ID: 1333573
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by L-NG-nitro-L-arginine of nonadrenergic-noncholinergic-mediated relaxations of human isolated central and peripheral airway.
Ellis JL; Undem BJ
Am Rev Respir Dis; 1992 Dec; 146(6):1543-7. PubMed ID: 1456572
[TBL] [Abstract][Full Text] [Related]
19. Peptide histidine isoleucine and vasoactive intestinal polypeptide cause relaxation of opossum internal anal sphincter via two distinct receptors.
Nurko S; Dunn BM; Rattan S
Gastroenterology; 1989 Feb; 96(2 Pt 1):403-13. PubMed ID: 2535995
[TBL] [Abstract][Full Text] [Related]
20. The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans.
Barnes PJ; Dixon CM
Am Rev Respir Dis; 1984 Aug; 130(2):162-6. PubMed ID: 6465669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
